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Lethal respiratory failure 
due to a surfactant protein 
C gene mutation
ABSTRACT
A case of a full-term male infant with recurrent episodes of „obstructive bronchitis” and „bilateral pneumonias”, refractory 
to conventional asthma therapy, is reported. When referred to the paediatric clinic at the age of 15 months, his clinical pre-
sentation was of acute respiratory distress syndrome with severe hypoxemia, which was easily corrected by the inhalation 
of oxygen. A series of further investigations, including lung biopsy, suggested the diagnosis of childhood interstitial lung 
disease (ILD). Due to progressive respiratory failure, the boy died after 3 months of mechanical ventilator support, at the 
age of 19 months. Subsequently performed genetic studies revealed that he was heterozygous for the I73T mutation of the 
surfactant protein C precursor protein. Thus, suspicion of childhood ILD due to genetic mutations that influence surfactant 
metabolism should be raised in children who present with unexplained respiratory distress or chronic respiratory symptoms. 
Less invasive testing, such as surfactant protein genetics, may be diagnostic in such cases.
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Introduction
Consideration of childhood interstitial 
lung disease (ILD) due to genetic muta-
tions that influence surfactant metabol-
ism should be raised in children who 
present with acute or chronic respira-
tory symptoms in the absence of known 
causes of respiratory distress or lung 
disease. (1) 
Case report
A 15-month old boy was transferred 
from a paediatric department of a gen-
eral hospital to the paediatric clinic 
because of acute exacerbation of his 
chronic respiratory symptoms. The boy 
was tachypneic and cyanotic on admis-
sion and needed oxygen administration 
by mask. Without oxygen supplementa-
tion his blood saturation immediately 
dropped to 40% and vice versa - severe 
hypoxemia was promptly corrected by 
the inhalation of oxygen. The boy was 
immediately admitted to the paediatric 
intensive care unit. At initial assessment 
digital clubbing, as a sign of chronic 
hypoxemia, was noticed. Blood gases 
analysis showed a normal blood car-
bon dioxide partial pressure (pCO2) 
value. The ratio of blood oxygen partial 
pressure (pO2) to fraction of inhaled 
oxygen (FiO2) was 135. Echocardiog-
raphy displayed a normal image of the 
heart and great vessels. Chest radiog-
raphy showed bilateral lung infiltrates 
suggesting acute respiratory distress 
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syndrome (figure 1). Chest ausculta-
tion revealed normal breath sounds 
in both lungs. There were no adventi-
tious sounds, including wheezing or 
crackles. The boy had severe failure to 
thrive with a body weight of 7700 g.
Birth history (birth weight 3300 g; Apgar 
score 10/10), as well as his growth and 
development until the age of 7 months, 
were unremarkable. Then, recurrent epi-
sodes of ”obstructive bronchitis“ and 
”bilateral pneumonias“, usually trig-
gered by viral airway infections, started 
to characterize his clinical presenta-
tions. During the following 8 months he 
was hospitalized four times at various 
paediatric departments and underwent 
many investigations including chest 
radiography, sweat tests and skin prick 
tests. Several consultants concluded 
that the boy was an immunocompetent, 
non-atopic subject who did not suffer 
from cystic fibrosis. He was treated with 
bronchodilators, inhaled corticosteroids 
and antileukotrienes, with no effect.
When referred to the paediatric cli-
nic, a series of further investigations 
were performed. Bronchoscopy reve-
aled normal visual findings. However, 
high–resolution computed tomography 
(HRCT) of the thorax showed impre-
ssive widespread changes (figure 2). 
Since the boy's condition deteriora-
ted, open lung biopsy was performed. 
Microscopic examination showed an 
organising phase of diffuse alveolar 
damage which appeared to be supe-
rimposed on hypoplastic lung.
In spite of the administration of corticoste-
roids, azathioprine, hydroxychloroquine 
and intravenous immunoglobulins, the 
boy´s condition continued to be critical. 
The progressive respiratory failure led 
to mechanical ventilation dependency, 
characterized by a continuous increase 
in mean airway pressure and FiO2 to 
maintain acceptable blood gas levels. 
Three doses of exogenous surfactant 
were administered with only short-term 
benefit. A trial of high frequency oscilla-
tory ventilation was performed but the 
boy was unresponsive to unconventio-
nal ventilation. He died after 3 months 
of mechanical ventilator support, at the 
age of 19 months.
Subsequently performed genetic studi-
es revealed that the boy was heterozy-
gous for the I73T gene mutation of the 
surfactant protein C (SP-C). Gene anal-
ysis for ABCA3 mutation was negative. 
His healthy unrelated parents did not 
wish to have their DNA analysed. They 
have two healthy daughters.
Discussion
Children younger than 15 months of 
age who have recurrent respiratory 
symptoms, with a fluctuating level of 
wheeze and dyspnea, may have deve-
loped symptoms following acute viral 
bronchiolitis, may have one of the asth-
ma phenotypes, or may have some 
other disorder including childhood ILD 
syndrome. (2) ILD is a rare diagnosis 
in children and its clinical presenta-
tion can be very nonspecific. Severe 
hypoxemia with normal pCO2, which 
was easily corrected with administration 
of oxygen, presence of finger clubbing 
and spectacular weight loss were clues 
to the diagnosis of ILD in the reported 
case. Diagnosis is usually confirmed 
by HRCT, but most patients will need 
to proceed to surgical lung biopsy for 
definitive diagnosis. (3)
The boy in our case showed no particu-
lar benefit from exogenous surfactant 
administration. The turn-over period of 
exogenous surfactant determines only 
temporary and partial improvement of 
lung compliance and gas exchange 
since there is no restoration of endo-
genous surfactant activity due to the 
genetic error. The progressive charac-
ter of the disease, as well as the transi-
ent response to surfactant replacement 
therapy, was also the standpoint for 
the diagnosis of ILD due to surfactant 
deficiency.
Childhood ILD comprises a much wider 
spectrum of conditions than the adult 
version. Genetic mutations in genes 
that influence surfactant metabolism, 
including SP-B, SP-C and ABCA3, can 
result in several histologic forms of ILD. 
Thus, less invasive testing, such as 
surfactant protein genetics, may be 
diagnostic in a certain proportion of 
cases. (4) The I73T mutation is the most 
frequently identified SP-C gene muta-
tion, and has accounted for approxi-
mately 30% of at least 35 mutations 
described in patients with lung disease 
due to SP-C gene mutations. (5) There 
is tremendous variability in the severity 
of the lung disease associated with this 
mutation. Some children die in early 
infancy, whereas other subjects with 
the mutation do not develop pulmonary 
symptoms until the fifth or sixth decade 
of life. (6) It is not clear why the lung 
disease is more severe in some indi-
viduals. In a small proportion of such 
patients it was found that they were also 
carriers for an ABCA3 mutation. (7)
Given that lung disease due to SP-C 
mutation can be familial and transmitted 
in an autosomal dominant pattern, the 
possibility of testing the boy´s parents 
Figure 1. Chest radiograph on admi-
ssion to the clinic, at age 15 months, 
showed bilateral fluffy alveolar infil-
trates.
Figure 2. High-resolution computed 
tomography of the chest showed 
diffuse bilateral air space consolida-
tion with air bronchograms.
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for this mutation was discussed. Beca-
use of the variable severity of lung dise-
ase associated with this mutation, it is 
quite possible that one of them has the 
mutation, and is currently without symp-
toms, but at risk for developing ILD in 
the future. However, their reluctance 
to perform the analysis was somewhat 
understandable as there is currently 
no specific treatment for the lung dise-
ase due to SP-C gene mutations. (8) 
Furthermore, history revealed that no 
other family members or relatives died 
from unexplained lung disease or had 
a life-long history of chronic respiratory 
problems or atypical asthma. Suppo-
sing that neither parent carries the I73T 
mutation, then it could be a de novo 
mutational event causing sporadic lung 
disease in the boy. In such a scenario, 
the chances of parents having another 
affected child would be very small but 
unfortunately not zero due to possible 
germ-line mosaicism.
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